Danaher (DHR) Competitors $205.42 +0.42 (+0.21%) Closing price 08/28/2025 03:59 PM EasternExtended Trading$205.84 +0.41 (+0.20%) As of 06:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DHR vs. RGEN, A, CR, CSL, GFF, IQV, MTD, TMO, WAT, and MMMShould you be buying Danaher stock or one of its competitors? The main competitors of Danaher include Repligen (RGEN), Agilent Technologies (A), Crane (CR), Carlisle Companies (CSL), Griffon (GFF), IQVIA (IQV), Mettler-Toledo International (MTD), Thermo Fisher Scientific (TMO), Waters (WAT), and 3M (MMM). Danaher vs. Its Competitors Repligen Agilent Technologies Crane Carlisle Companies Griffon IQVIA Mettler-Toledo International Thermo Fisher Scientific Waters 3M Danaher (NYSE:DHR) and Repligen (NASDAQ:RGEN) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings. Do insiders and institutionals hold more shares of DHR or RGEN? 79.1% of Danaher shares are owned by institutional investors. Comparatively, 97.6% of Repligen shares are owned by institutional investors. 11.1% of Danaher shares are owned by insiders. Comparatively, 1.2% of Repligen shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts rate DHR or RGEN? Danaher presently has a consensus target price of $247.61, suggesting a potential upside of 20.54%. Repligen has a consensus target price of $169.45, suggesting a potential upside of 38.70%. Given Repligen's higher probable upside, analysts plainly believe Repligen is more favorable than Danaher.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Danaher 0 Sell rating(s) 3 Hold rating(s) 17 Buy rating(s) 0 Strong Buy rating(s) 2.85Repligen 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73 Which has more risk & volatility, DHR or RGEN? Danaher has a beta of 0.73, indicating that its stock price is 27% less volatile than the S&P 500. Comparatively, Repligen has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Does the media favor DHR or RGEN? In the previous week, Danaher had 28 more articles in the media than Repligen. MarketBeat recorded 45 mentions for Danaher and 17 mentions for Repligen. Danaher's average media sentiment score of 1.62 beat Repligen's score of 1.33 indicating that Danaher is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Danaher 43 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Repligen 13 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings & valuation, DHR or RGEN? Danaher has higher revenue and earnings than Repligen. Repligen is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDanaher$23.88B6.16$3.90B$4.7043.71Repligen$634.44M10.83-$25.51M-$0.25-488.68 Is DHR or RGEN more profitable? Danaher has a net margin of 14.21% compared to Repligen's net margin of -2.05%. Danaher's return on equity of 10.70% beat Repligen's return on equity.Company Net Margins Return on Equity Return on Assets Danaher14.21% 10.70% 6.85% Repligen -2.05%4.61%3.24% SummaryDanaher beats Repligen on 12 of the 16 factors compared between the two stocks. Get Danaher News Delivered to You Automatically Sign up to receive the latest news and ratings for DHR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DHR vs. The Competition Export to ExcelMetricDanaherMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$146.79B$7.69B$5.78B$21.30BDividend Yield0.62%2.73%3.95%3.51%P/E Ratio43.7178.2431.2429.34Price / Sales6.1645.60429.4950.88Price / Cash18.7624.7637.7323.86Price / Book2.8121.7310.365.39Net Income$3.90B$242.04M$3.27B$996.59M7 Day Performance-2.97%-0.92%1.40%0.41%1 Month Performance-0.68%2.64%6.21%3.49%1 Year Performance-23.11%9.98%46.60%12.09% Danaher Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DHRDanaher4.8396 of 5 stars$205.42+0.2%$247.61+20.5%-22.8%$146.79B$23.88B43.7163,000Positive NewsRGENRepligen4.8619 of 5 stars$121.26-2.8%$169.45+39.7%-16.0%$6.82B$634.44M-485.021,778Positive NewsAAgilent Technologies4.705 of 5 stars$119.15-2.0%$139.77+17.3%-11.3%$33.85B$6.51B29.4217,900Trending NewsEarnings ReportAnalyst ForecastCRCrane4.6236 of 5 stars$192.24-1.0%$222.20+15.6%+23.8%$11.06B$2.23B25.4611,000Trending NewsInsider TradeCSLCarlisle Companies4.4241 of 5 stars$393.08-1.1%$450.83+14.7%-7.3%$16.80B$5.00B21.965,500GFFGriffon4.8522 of 5 stars$75.80+0.3%$98.20+29.6%+19.4%$3.53B$2.62B56.575,300Positive NewsIQVIQVIA4.9108 of 5 stars$188.08-1.6%$228.62+21.6%-23.8%$31.97B$15.41B27.2288,000Positive NewsMTDMettler-Toledo International4.0743 of 5 stars$1,289.88-2.4%$1,311.11+1.6%-9.8%$26.57B$3.87B32.6617,300Positive NewsTMOThermo Fisher Scientific4.948 of 5 stars$490.73-1.9%$593.00+20.8%-20.0%$185.31B$42.88B28.38125,000Positive NewsInsider TradeWATWaters4.7735 of 5 stars$299.25-1.0%$378.73+26.6%-12.8%$17.81B$2.96B26.987,600Trending NewsMMM3M3.9655 of 5 stars$155.91-1.3%$158.10+1.4%+19.7%$83.04B$24.58B21.6861,500Positive News Related Companies and Tools Related Companies RGEN Alternatives A Alternatives CR Alternatives CSL Alternatives GFF Alternatives IQV Alternatives MTD Alternatives TMO Alternatives WAT Alternatives MMM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DHR) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Danaher Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Danaher With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access